Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine ...

We recently compiled a list of the Top 10 AI-Powered Biotech Stocks to Buy Right Now. Caris Life Sciences, Inc. is among the best biotech stocks. TheFly reported on April 10 that Piper Sandler began ...

A common gut bacterium may be implicated in lupus kidney disease, and could potentially alter the diagnosis and treatment of ...

According to a new report published by Allied Market Research, the global Genomics Services Market was valued at $8.3 billion ...

A robust and quantitative map links chromatin modification and gene expression of cells during zebrafish embryogenesis.

Genomics, Inc. , a leader in single cell and spatial biology, today announced Atera, a new in situ spatial biology platform engineered to deliver whole-transcriptome spatial analysis with single-cell ...

Qlucore, listed on Nasdaq First North, is launching a new Qlucore Insights test (Research Use Only) specifically developed for bladder cancer samples. The software-based test delivers multiple ...

Researchers explored the cellular cross-talk between endothelial cells and macrophages contributing to peripheral vascular ...

IRVING, Texas, April 20, 2026 /PRNewswire/ -- Caris Life Sciences (R) (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced it ...

This week in science news: Researchers are calling to exploit sewage waste and manure to break U.S. synthetic fertilizer ...

Target identification is a critical and challenging step in drug discovery, with only a small fraction of human genes ...

(spidroins) through long-read transcriptomics across a broad phylogenetic range, with theoretical implications for protein family evolution, biomaterials, and silk biology. By identifying putative ...